SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-040721
Filing Date
2022-02-14
Accepted
2022-02-14 12:30:53
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INCGV 2016 GP, L.L.C.GV 2016 GP, L.P.GV 2017 GP, L.L.C.GV 2017 GP, L.P.GV 2017, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d158263dsc13ga.htm SC 13G/A 182745
2 EX-99.A d158263dex99a.htm EX-99.A 12133
  Complete submission text file 0001193125-22-040721.txt   196584
Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2016, L.P. (Filed by) CIK: 0001721789 (see all company filings)

IRS No.: 611775632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Subject) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90423 | Film No.: 22628115
SIC: 2834 Pharmaceutical Preparations